Clinical Trial Update: Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results evaluating rabeprazole for gastroesophageal reflux disease in adolescents aged 12-16 were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Eisai Inc. | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-12-03